We noted considerable genetic heterogeneity in our cohort with 16 different pathogenic variants identified of which 11 have not been reported previously (Fig
Personalized protocols based on individual biology are becoming increasingly feasible
Given these potential mechanisms, this study was designed to test the hypothesis that DIO mice restored to the weight and adiposity of LD controls through NNMTi treatment and LD switch 13 have a similar microbiome profile to mice continuously maintained on LD
Older adults seeking to combat the signs of aging, improve skin health, and enhance overall vitality can benefit from peptide therapy
This multifaceted action underscores the potential of bevacizumab as a therapeutic agent not only in AD but also in various other neurodegenerative and neuroinflammatory conditions
As Imperial College Londons Ivan Koychev noted: People exposed to GLP-1RAs over many years appear to have a lower risk of ever developing dementia, which suggests an influence on the earliest pathogenic processes rather than on established neurodegeneration. 2